MAST CELL LEUKEMIA

Clinical trials for MAST CELL LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new MAST CELL LEUKEMIA trials appear

Sign up with your email to follow new studies for MAST CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New targeted pill shows promise for rare blood cancer

Disease control Completed

This Phase 2 study tested avapritinib, a daily tablet that targets a specific genetic mutation, in 107 people with advanced systemic mastocytosis (a rare blood cancer). The main goal was to see how many patients had their tumors shrink or symptoms improve. Results suggest the dru…

Matched conditions: MAST CELL LEUKEMIA

Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

MAST CELL LEUKEMIA

Get alerted when new MAST CELL LEUKEMIA trials appear

New targeted pill shows promise for rare blood cancer